Patents Assigned to Biogazelle NV
  • Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA
    Patent number: 11021707
    Abstract: The present disclosure relates to RNAi constructs with improved cellular uptake characteristics and methods of use of these compounds for silencing expression of long coding RNAs (IncRNAs).
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: June 1, 2021
    Assignees: Phio Pharmaceuticals Corp., Biogazelle NV
    Inventors: James Cardia, Karen G. Bulock, Joke Hedwig Vandesompele, Gert Van Peer
  • REDUCED SIZE SELF-DELIVERING NUCLEIC ACID COMPOUNDS TARGETING LONG NON-CODING RNA
    Publication number: 20190048341
    Abstract: The present disclosure relates to RNAi constructs with improved cellular uptake characteristics and methods of use of these compounds for silencing expression of long coding RNAs (IncRNAs).
    Type: Application
    Filed: October 19, 2016
    Publication date: February 14, 2019
    Applicants: RXi Pharmaceuticals Corporation, Biogazelle NV
    Inventors: James Cardia, Karen G. Bulock, Joke Hedwig Vandesompele, Gert Van Peer